1BVK image
Entry Detail
PDB ID:
1BVK
Title:
HUMANIZED ANTI-LYSOZYME FV COMPLEXED WITH LYSOZYME
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
1998-09-16
Release Date:
1999-02-16
Method Details:
Experimental Method:
Resolution:
2.70 Å
R-Value Free:
0.29
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 41 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:HULYS11
Chain IDs:A, D
Chain Length:108
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:HULYS11
Chain IDs:B, E
Chain Length:117
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:LYSOZYME
Chain IDs:C, F
Chain Length:129
Number of Molecules:2
Biological Source:Gallus gallus
Ligand Molecules
Primary Citation
Conformational correction mechanisms aiding antigen recognition by a humanized antibody.
J.Exp.Med. 187 479 485 (1998)
PMID: 9463398 DOI: 10.1084/jem.187.4.479

Abstact

The crystal structure of the complex between hen egg lysozyme and the Fv fragment of a humanized antilysozyme antibody was determined to 2.7-A resolution. The structure of the antigen combining site in the complex is nearly identical to that of the complexed form of the parent mouse antibody, D1.3. In contrast, the combining sites of the unliganded mouse and humanized antilysozymes show moderate conformational differences. This disparity suggests that a conformational readjustment process linked to antigen binding reverses adverse conformations in the complementarity determining regions that had been introduced by engineering these segments next to human framework regions in the humanized antibody.

Legend

Protein

Chemical

Disease

Primary Citation of related structures